Naltrexone decreases craving and alcohol self-administration in alcohol-dependent subjects and activates the hypothalamo-pituitary-adrenocortical axis

Psychopharmacology

Volumn 160, Issue 1, 2002, Pages 19-29

  O'Malley, Stephanie S ^a   Krishnan Sarin, Suchitra ^a   Farren, Conor ^a   Sinha, Rajita ^a   Kreek, Mary ^b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ROCKEFELLER UNIVERSITY   (United States)

Author keywords

ACTH; Alcohol dependence; Cortisol; Craving; Drinking; Hypothalamo pituitary adrenocortical (HPA) axis; Laboratory paradigms; Naltrexone; Neuroendocrine response; Opiate antagonist; Self administration

Indexed keywords

CORTICOTROPIN; HYDROCORTISONE; NALTREXONE; PROLACTIN;

ADULT; ALCOHOL BLOOD LEVEL; ALCOHOL CONSUMPTION; ALCOHOLISM; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORTICOTROPIN BLOOD LEVEL; DRINKING BEHAVIOR; DRUG EFFECT; FEMALE; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MALE; NAUSEA; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; RELAPSE; WITHDRAWAL SYNDROME;

ADRENOCORTICOTROPIC HORMONE; ADULT; ALCOHOL DRINKING; ALCOHOLISM; CENTRAL NERVOUS SYSTEM DEPRESSANTS; ETHANOL; HUMANS; HYDROCORTISONE; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MALE; NALTREXONE; NARCOTIC ANTAGONISTS; NAUSEA; PITUITARY-ADRENAL SYSTEM; PSYCHIATRIC STATUS RATING SCALES; QUESTIONNAIRES;

EID: 0036181179     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002130100919     Document Type: Article

References (52)

1. Hypothalamic-pituitary-adrenal axis functioning and cerebrospinal fluid corticotropin levels in alcoholics after recent and long-term abstinence
2. Naltrexone and cognitive behavior therapy for the treatment of outpatient alcoholics: Results of a placebo-controlled trial
3. Endocrine and metabolic effects of opiate antagonists
4. Effects of third intracerebroventricular injections of corticotropin-releasing factor (CRF) on ethanol drinking and food intake
5. Diminished adrenocorticotropin response to insulin-induced hypoglycemia in nondepressed, actively drinking male alcoholics
6. Development and initial validation of a measure of drinking urges in abstinent alcoholics
7. The economic context of drug and non-drug reinforcers affects acquisition and maintenance of drug-reinforced behavior and withdrawal effects
8. Hormonal effects of high dose naloxone in humans
9. Naltrexone increases the latency to drink alcohol in social drinkers
10. Effects of naltrexone on alcohol self-administration in heavy drinkers
11. Effects of naltrexone pretreatment on the subjective and performance effects of ethanol in social drinkers
12. Behavioral responses to ethanol in light and moderate social drinkers
13. Behavioral economic-analysis of smoking - Money and food as alternatives
14. The influence of alternative reinforcers on cocaine use and abuse: A brief review
15. The effects of alcoholism on the hypothalamic-pituitary-adrenal axis: Interaction with endogenous opioid peptides
16. Effect of opioid antagonism on B-endorphin processing and proopiomelanocor-tin-peptide release in the hypothalamus
17. Opioids excite dopamine neurons by hyperpolarization of local interneurons
18. Effect of nal-trexone on subjective alcohol response in subjects at high and low risk for future alcohol dependence
19. Regulation of somatodendritic dopamine release in the ventral tegmental area by opioids and GABA: An in vivo microdialysis study
20. A preliminary study of beta endorphin during chronic naltrexone maintenance treatment in ex-opiate addicts
21. Prolonged (24hour) infusion of the opioid antagonist naloxone does not significantly alter plasma levels of cortisol and ACTH in humans
22. Free choice ethanol consumption by rats: Effects of ACTH
23. Naloxone challenge in smokers: Preliminary evidence of an opioid component in nicotine dependence
24. Chronic naloxone results in prolonged increases in opiate binding sites in the brain
25. A double-blind, placebo-controlled pilot study to evaluate the efficacy and safety of oral nalmefene HCI for alcohol dependence
26. A double-blind placebo-controlled study of oral nalmefene for alcohol dependence
27. Naltrexone alters subjective psychomotor responses to alcohol in heavy drinking subjects
28. Naloxone effects on beta-endorphin, cortisol, prolactin, growth hormone, HVA, and MHPG in plasma of normal volunteers
29. Naltrexone and coping skills therapy for alcohol dependence: A controlled study
30. Naltrexone in the treatment of alcohol dependence: A combined analysis of two trials
31. Naltrexone induced nausea in patients treated for alcohol dependence: Clinical predictors and evidence for opioid mediated effects
32. The concept of craving and its measurement
33. Effects of buprenorphine and an alternative nondrug reinforcer, alone and in combination on smoked cocaine self-administration in monkeys
34. Nalmefene causes greater hypothalamic-pituitary-adrenal axis activation than naloxone in normal volunteers: Implications for the treatment of alcoholism
35. Naturalistic follow-up of drinking behavior following participation in an alcohol administration study
36. Timeline follow-back: A technique for assessing self-reported alcohol consumption
37. Differences in baseline drinking behaviour between alcoholics and normal drinker
38. Naltrexone-induced alterations in human ethanol intoxication
39. Alcohol effects on naltrexone-induced stimulation of pituitary, adrenal, and gonadal hormones during the early follicular phase of the menstrual cycle
40. Chronic opioid antagonist administration upregulates mu opioid receptor binding without altering mu opioid receptor mRNA levels
41. Hormonal (ACTH, cortisol,B-endorphin, and met-enkephalin) and cardiovascular responses to hyperthermic stress in chronic alcoholics
42. Naltrexone in the treatment of alcohol dependence
43. Naltrexone and alcohol dependence: Role of subject compliance
44. Alcohol and the hypothalamic-pituitary-adrenal axis
45. Alterations in the hypothalamic-pituitary-adrenal axis in actively drinking alcoholics
46. Adrenocortical responses and family history of alcoholism
47. Total body water and blood alcohol levels: Updating the fundamentals
48. Ethanol-induced increase in endogenous dopamine release may involve endogenous opiates
49. Super-sensitivity to opioid analgesics following chronic opioid antagonist treatment: Relationship to receptor selectivity